Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals

Jamie Perin, Amy Mulick, Diana Yeung, Francisco Villavicencio, Gerard Lopez, Kathleen L Strong, David Prieto-Merino, Simon Cousens, Robert E Black, Li Liu, Jamie Perin, Amy Mulick, Diana Yeung, Francisco Villavicencio, Gerard Lopez, Kathleen L Strong, David Prieto-Merino, Simon Cousens, Robert E Black, Li Liu

Abstract

Background: Causes of mortality are a crucial input for health systems for identifying appropriate interventions for child survival. We present an updated series of cause-specific mortality for neonates and children younger than 5 years from 2000 to 2019.

Methods: We updated cause-specific mortality estimates for neonates and children aged 1-59 months, stratified by level (low, moderate, or high) of mortality. We made a substantial change in the statistical methods used for previous estimates, transitioning to a Bayesian framework that includes a structure to account for unreported causes in verbal autopsy studies. We also used systematic covariate selection in the multinomial framework, gave more weight to nationally representative verbal autopsy studies using a random effects model, and included mortality due to tuberculosis.

Findings: In 2019, there were 5·30 million deaths (95% uncertainty range 4·92-5·68) among children younger than 5 years, primarily due to preterm birth complications (17·7%, 16·1-19·5), lower respiratory infections (13·9%, 12·0-15·1), intrapartum-related events (11·6%, 10·6-12·5), and diarrhoea (9·1%, 7·9-9·9), with 49·2% (47·3-51·9) due to infectious causes. Vaccine-preventable deaths, such as for lower respiratory infections, meningitis, and measles, constituted 21·7% (20·4-25·6) of under-5 deaths, and many other causes, such as diarrhoea, were preventable with low-cost interventions. Under-5 mortality has declined substantially since 2000, primarily because of a decrease in mortality due to lower respiratory infections, diarrhoea, preterm birth complications, intrapartum-related events, malaria, and measles. There is considerable variation in the extent and trends in cause-specific mortality across regions and for different strata of all-cause under-5 mortality.

Interpretation: Progress is needed to improve child health and end preventable deaths among children younger than 5 years. Countries should strategize how to reduce mortality among this age group using interventions that are relevant to their specific causes of death.

Funding: Bill & Melinda Gates Foundation; WHO.

Conflict of interest statement

Declaration of interests We declare no competing interests.

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Global causes of under-5 deaths in 2019 Deaths of neonates (aged 0–27 days) are on the right-hand side and deaths of children aged 1–59 months are on the left-hand side.
Figure 2
Figure 2
Cause-specific under-5 mortality in 2019 (A) Cause-of-death mortality fraction. (B) Mortality per 1000 livebirths. Mortality strata are defined as very low (100 deaths per 1000 livebirths).
Figure 3
Figure 3
Global trends in cause-specific mortality rates in neonates and children aged 1–59 months, 2000–19 The length of each bar represents the amount of change in all-cause under five mortality rate attributable to changes in the mortality rate for each cause. The numbers above the bars are the change in each cause-specific mortality rate. *63% of the reduction is due to lower respiratory infections, diarrhoea, neonatal preterm birth complications, neonatal intrapartum-related events, malaria, and measles.
Figure 4
Figure 4
Projected cause-specific progress needed to meet the SDG child survival target for under-5 mortality by 2030 The SDG target for mortality in children younger than 5 years is 100 deaths per 1000 livebirths; eg, Nigeria). SDG=Sustainable Development Goals.

References

    1. UN The millennium development goals report 2015. Sept 15, 2015.
    1. UN General Assembly Transforming our world: the 2030 Agenda for Sustainable Development. September, 2015.
    1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027–3035.
    1. Efron B. Cambridge University Press; Cambridge: 2012. Large-scale inference: empirical Bayes methods for estimation, testing, and prediction.
    1. Mulick AR, Oza S, Prieto-Merino D, Villavicencio F, Cousens S, Perin J. A Bayesian hierarchical model with integrated covariate selection and misclassification matrices to estimate neonatal and child causes of death. medRxiv. 2021 published online Feb 12. (preprint).
    1. He C, Liu L, Chu Y, et al. National and subnational all-cause and cause-specific child mortality in China, 1996–2015: a systematic analysis with implications for the Sustainable Development Goals. Lancet Glob Health. 2017;5:e186–e197.
    1. UN Inter-agency Group for Child Mortality Estimation Levels and trends in child mortality 2020. September, 2020.
    1. Wang H, Abbas KM, Abbasifard M, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1160–1203.
    1. WHO World malaria report 2020: 20 years of global progress and challenges. Nov 30, 2020.
    1. WHO Global tuberculosis report 2020. Oct 15, 2020.
    1. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367:348–361.
    1. WHO MCEE-WHO methods and data sources for child causes of death 2000-2017. December, 2018.
    1. UNICEF Malnutrition amongst children in Yemen at an all-time high, warns UNICEF. Dec 12, 2016.
    1. França GV, Schuler-Faccini L, Oliveira WK, et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet. 2016;388:891–897.
    1. Daniels JP. Venezuela in crisis. Lancet Infect Dis. 2019;19:28.
    1. Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med. 2016;13
    1. Finnegan KE, Haruna J, Cordier LF, et al. Rapid response to a measles outbreak in Ifanadiana District, Madagascar. medRxiv. 2020 published online Dec 2. (preprint).
    1. WHO Deaths from Democratic Republic of the Congo measles outbreak top 6000. Jan 7, 2020.
    1. Ahmed I, Ali SM, Amenga-Etego S, et al. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. Lancet Glob Health. 2018;6:e1297–e1308.
    1. Mathers CD. History of global burden of disease assessment at the World Health Organization. Arch Public Health. 2020;78:77.
    1. WHO Global Health Estimates 2019: deaths by cause, age, sex, by country and by region, 2000–2019. 2020.
    1. Nalin DR, Cash RA. 50 years of oral rehydration therapy: the solution is still simple. Lancet. 2018;392:536–538.
    1. Davis WA, Clarke PM, Siba PM, et al. Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea. Bull World Health Organ. 2011;89:211–220.
    1. Okwaraji YB, Cousens S, Berhane Y, Mulholland K, Edmond K. Effect of geographical access to health facilities on child mortality in rural Ethiopia: a community based cross sectional study. PLoS One. 2012;7
    1. Larson Williams A, Mitrovich R, Mwananyanda L, Gill C. Maternal vaccine knowledge in low- and middle-income countries-and why it matters. Hum Vaccin Immunother. 2019;15:283–286.
    1. Requejo J, Strong K. British Medical Journal Publishing Group; London: 2021. Redesigning health programmes for all children and adolescents.
    1. Keenan JD, Arzika AM, Maliki R, et al. Longer-term assessment of azithromycin for reducing childhood mortality in Africa. N Engl J Med. 2019;380:2207–2214.
    1. Keenan JD, Bailey RL, West SK, et al. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N Engl J Med. 2018;378:1583–1592.
    1. Khanam R, Baqui AH, Syed MIM, et al. Can facility delivery reduce the risk of intrapartum complications-related perinatal mortality? Findings from a cohort study. J Glob Health. 2018;8
    1. Mukuru M, Kiwanuka SN, Gibson L, Ssengooba F. Challenges in implementing emergency obstetric care (EmOC) policies: perspectives and behaviours of frontline health workers in Uganda. Health Policy Plan. 2021;36:260–272.
    1. Burke M, Heft-Neal S, Bendavid E. Sources of variation in under-5 mortality across sub-Saharan Africa: a spatial analysis. Lancet Glob Health. 2016;4:e936–e945.
    1. Phillips DE, AbouZahr C, Lopez AD, et al. Are well functioning civil registration and vital statistics systems associated with better health outcomes? Lancet. 2015;386:1386–1394.
    1. Kc A, Gurung R, Kinney MV, et al. Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study. Lancet Glob Health. 2020;8:e1273–e1281.
    1. Hartnett KP, Kite-Powell A, DeVies J, et al. Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:699–704.

Source: PubMed

3
Sottoscrivi